GlaxoSmithKline S.A.E (EGX: BIOC)

Market Cap	3.40B
Revenue (ttm)	2.81B
Net Income (ttm)	119.55M
Shares Out	83.51M
EPS (ttm)	1.43
PE Ratio	28.52
Forward PE	n/a
Dividend	0.75 (1.85%)
Ex-Dividend Date	Jul 18, 2024

Volume	52,578
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	24.70 - 47.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in the production of pharmaceutical chemicals in Egypt. It is also involved in the manufacture of medical preparations and cosmetics. The company was founded in 1981 and is headquartered in New Cairo City, Egypt. GlaxoSmithKline S.A.E. operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2023, GlaxoSmithKline S.A.E's revenue was 2.24 billion, an increase of 22.87% compared to the previous year's 1.82 billion. Earnings were 60.46 million, a decrease of -91.78%.